Viewing Study NCT00013806


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2025-12-26 @ 4:02 PM
Study NCT ID: NCT00013806
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-03-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study
Sponsor: National Center for Research Resources (NCRR)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module